Edition:
United Kingdom

People: Align Technology Inc (ALGN.OQ)

ALGN.OQ on NASDAQ Stock Exchange Global Select Market

281.21USD
19 Jul 2019
Change (% chg)

$-2.16 (-0.76%)
Prev Close
$283.37
Open
$284.57
Day's High
$288.36
Day's Low
$280.00
Volume
388,325
Avg. Vol
390,453
52-wk High
$398.46
52-wk Low
$178.01

Morrow, George 

Mr. George J. Morrow is Independent Director of the Company. Mr. Morrow has served as a director of Align since February 2006. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He currently serves on the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products, and Neurocrine Biosciences, a biotechnology company focused on neurologic, psychiatric and endocrine related disorders. He also served on the board of Safeway Inc., a food and drug retailer from May 2013 until February 2015 From April 2015 to June 2018, he served on the board of Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Basic Compensation

Total Annual Compensation, USD 82,000
Restricted Stock Award, USD 300,054
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 382,054

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Charles Larkin

536,931

Joseph Hogan

41,758,300

John Morici

3,355,180

Zelko Relic

3,078,030

Raj Pudipeddi

--

Simon Beard

--
As Of  31 Dec 2018